Logo

Accelrys Receives Nasdaq Compliance Notice After Failure to File Financial Report

Feb 20, 2006

NEW YORK, Feb. 20 (GenomeWeb News) - Accelrys said on Friday that it has received a notice from the Nasdaq that the company is not in compliance with the exchange's rules after failing to file its fourth-quarter financial report on time.

 

Accelrys said the notice was expected, and that it "remains in continuing discussions with the [US] Securities and Exchange Commission with respect to the accounting treatment for certain of its contracts."

 

The company said that it cannot identify a time when its financial report will be filed, and that it plans to request a hearing before the Nasdaq Listing Qualifications Panel in order to ask for a continued listing of its stock while it completes its financial report.

Breaking News
The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.